The Cosmetic Treatment market is similarly dissected by application, but its emphasis differs in patient intent and procedural frequency. Anti‑aging applications—targeting fine lines, volume loss, and skin laxity—represent the largest share at approximately 48 %, driven by the widespread use of botulinum toxin and hyaluronic‑based fillers. Corrective applications—addressing scar revision, post‑procedural pigmentation, and vascular lesions—make up around 22 %, with chemical peels, laser therapy, and microneedling as the dominant types. The final 30 % is allocated to enhancement applications, including breast augmentation, rhinoplasty, and liposuction, where surgical and energy‑based modalities coexist. Each type contributes distinct cost structures: injectables and peels generate high volume, low‑margin revenue, whereas surgical enhancements yield lower volume but higher margins. Understanding this application‑type matrix is essential for forecasting growth trajectories within the Medical Aesthetics and Cosmetic Treatment market taxonomy.